A diet rich in medium-chain fatty acids improves systolic function and alters the lipidomic profile in patients with type 2 diabetes: A pilot study

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 2, 2016, Pages 504-512

  Airhart, Sophia ^a   Cade, W Todd ^b   Jiang, Hui ^c   Coggan, Andrew R ^d   Racette, Susan B ^b   Korenblat, Kevin ^e   Spearie, Catherine Anderson ^e   Waller, Suzanne ^e   O'Connor, Robert ^d   Bashir, Adil ^d   Ory, Daniel S ^c   Schaffer, Jean E ^c   Novak, Eric ^a   Farmer, Marsha ^c   Waggoner, Alan D ^b   Dávila Román, Víctor G ^b   Javidan Nejad, Cylen ^d   Peterson, Linda R ^b  

^a Program in Physical Therapy   (United States)

^b Department of Medicine Diabetic Cardiovascular Disease Center   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Div Gastroenterol Cedars Sinai M   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; ASPARTATE AMINOTRANSFERASE; CERAMIDE; INSULIN; LOW DENSITY LIPOPROTEIN; MEDIUM CHAIN FATTY ACID; SPHINGOLIPID; FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DOUBLE BLIND PROCEDURE; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; INSULIN BLOOD LEVEL; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEATOSIS; SYSTOLIC FUNCTION; BLOOD; BLOOD PRESSURE; DIET; DIET THERAPY; DRUG EFFECTS; HEART CONTRACTION; HEART FUNCTION TEST; LIPID METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SYSTOLE; TREATMENT OUTCOME;

ADULT; AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIET; DOUBLE-BLIND METHOD; FATTY ACIDS; FEMALE; HEART FUNCTION TESTS; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PILOT PROJECTS; PROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME;

EID: 84959431623     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3292     Document Type: Article

References (39)

1. Peterson LR, McKenzie CR, Schaffer JE. Diabetic cardiovascular disease: getting to the heart of the matter. J Cardiovasc Transl Res. 2012;5:436-445.
2. Peterson LR, Saeed IM, McGill JB, et al. Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans. Obesity (Silver Spring). 2012;20:802-810.
3. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97:1784-1789.
4. Chiu HC, Kovacs A, Ford DA, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest. 2001;107:813-822.
5. Finck BN, Lehman JJ, Leone TC, et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002;109:121-130.
6. Chiu HC, Kovacs A, Blanton RM, et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res. 2005;96:225-233.
7. Szczepaniak LS, Dobbins RL, Metzger GJ, et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med. 2003;49:417-423.
8. Hammer S, van der Meer RW, Lamb HJ, et al. Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2008; 295:E714-E718.
9. Straczkowski M, Kowalska I, Baranowski M, et al. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia. 2007;50:2366-2373.
10. Amati F, Dube JJ, Alvarez-Carnero E, et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes. 2011;60:2588-2597.
11. Mihalik SJ, Goodpaster BH, Kelley DE, et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring). 2010; 18:1695-1700.
12. Mitsutake S, Zama K, Yokota H, et al. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes. J Biol Chem. 2011;286:28544-28555.
13. Park TS,HuY,NohHL, et al. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res. 2008;49:2101-2112.
14. Russo SB, Baicu CF,VanLaer A, et al. Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes. J Clin Invest. 2012;122:3919-3930.
15. Adams SH, Hoppel CL, Lok KH, et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr. 2009;139:1073-1081.
16. Finck BN, Han X, Courtois M, et al. A critical role for PPARalphamediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci U S A. 2003;100:1226-1231.
17. Eckel RH, Hanson AS, Chen AY, Berman JN, Yost TJ, Brass EP. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes. 1992;41:641-647.
18. Prior IA, Davidson F, Salmond CE, Czochanska Z. Cholesterol, coconuts, and diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau island studies. Am J Clin Nutr. 1981;34: 1552-1561.
19. Stanhope JM, Sampson VM, Prior IA. The Tokelau Island Migrant Study: serum lipid concentration in two environments. J Chronic Dis. 1981;34:45.
20. Dayrit CS. Coconut oil: atherogenic or not? Phillipp J Cardiol. 2003; 31:97.
21. Wilson CR, Tran MK, Salazar KL, Young ME, Taegtmeyer H. Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem J. 2007;406:457-467.
22. Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab. 2005;289: E935-E939.
23. St-Onge MP, Jones PJ. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J Nutr. 2002; 132:329-332.
24. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. AmJ Physiol Endocrinol Metab. 2005;288:E462-E468.
25. Peronnet F, Massicotte D. Table of nonprotein respiratory quotient: an update. Can J Sport Sci. 1991;16:23-29.
26. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol. 1983;55:628-634.
27. Fan M, Sidhu R, Fujiwara H, et al. Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling. J Lipid Res. 2013;54:2800-2814.
28. Waggoner AD, Bierig SM. Tissue Doppler imaging: a useful echocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function. J Am Soc Echocardiogr. 2001; 14:1143-1152.
29. Hammer S, Snel M, Lamb HJ, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol. 2008;52:1006-1012.
30. Listenberger LL, Han X, Lewis SE, Cases S, Farese RVJ, Ory DS, Schaffer JE. Triglyceride accumulation protects against fatty acidinduced lipotoxicity. Proc Natl Acad Sci U S A. 2003;100:3077-3082.
31. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem. 2001;276:14890-14895.
32. Bieberich E. Ceramide signaling in cancer and stem cells. Future Lipidol. 2008;3:273-300.
33. Teichgraber V, Ulrich M, Endlich N, et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med. 2008;14:382-391.
34. Carracedo A, Geelen MJ, Diez M, Hanada K, Guzman M, Velasco G. Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids. Biochem J. 2004;380:435-440.
35. Lin CH, Kurup S, Herrero P, et al. Myocardial oxygen consumption change predicts left ventricular relaxation improvement in obese humans after weight loss. Obesity (Silver Spring). 2011;19:1804-1812.
36. Wessen J. Migration and Health in a Small Society: The Case of Tokelau (Research Monographs in Human Population Biology). New York, NY: Oxford University Press; 1992.
37. White MD, Papamandjaris AA, Jones PJ. Enhanced postprandial energy expenditure with medium-chain fatty acid feeDing is attenuated after 14 d in premenopausal women. Am J Clin Nutr. 1999; 69:883-889.
38. Scalfi L, Coltorti A, Contaldo F. Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long-chain triglycerides. Am J Clin Nutr. 1991;53:1130-1133.
39. Kasner M, Westermann D, SteenDijk P, et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation. 2007;116:637-647.